OMB APPROVAL   OMB Number: 3235-0145  Expires: February 28, 2009   Estimated average burden hours per response...10.4 

 

**UNITED STATES  SECURITIES AND EXCHANGE COMMISSION  WASHINGTON, D.C. 20549**

**SCHEDULE 13G**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934  (Amendment No.1)***

**Genvec, Inc.**  (Name of Issuer)

 Common Stock, $.001 par value  (Title of Class of Securities)

 37246C109  (CUSIP Number)

  December 31, 2003  (Date of Event Which Requires Filing of this Statement)

  Check the appropriate box to designate the rule pursuant to which this Schedule  is filed:

 |_| Rule 13d-1(b)  |x| Rule 13d-1(c)  |_| Rule 13d-1(d)

 *The remainder of this cover page shall be filled out for a reporting  person's initial filing on this form with respect to the subject class of  securities, and for any subsequent amendment containing information which would  alter disclosures provided in a prior cover page.

 The information required on the remainder of this cover page shall not be  deemed to be "filed" for the purpose of Section 18 of the Securities  Exchange  Act of 1934 ("Act") or otherwise subject to the liabilities of that  section of  the Act but shall be subject to all other provisions of the Act (however, see  the Notes).

 

CUSIP No.  37246C109  --------------------------------------------------------------------------------

1) Names of Reporting Persons. Warner-Lambert Company LLC  I.R.S. Identification Nos. of Above Persons (entities only) 22-1598912

--------------------------------------------------------------------------------

2) Check the Appropriate Box if a Member of a Group (See Instructions)  (a) |_|  (b) |_|

--------------------------------------------------------------------------------

3) SEC Use Only

--------------------------------------------------------------------------------

4) Citizenship or Place of Organization  Delaware

--------------------------------------------------------------------------------

| NUMBER OF          SHARES           BENEFICIALLY 

OWNED BY EACH REPORTING

 PERSON WITH:       | 5. Sole Voting Power  -0- |
|-------------------------------------------------------------------------------------------------|--------------------------------|
| 6. Shared Voting Power   1,925, 540      as of Aug. 2003; 7,486 as of 9/11/2007       |
| 7. Sole Dispositive Power  -0-                                                             |
| 8. Shared Dispositive Power    1,925,      540 as of Aug. 2003; 7,486 as of 9/11/2007 |

--------------------------------------------------------------------------------

9) Aggregate Amount Beneficially Owned by Each Reporting Person    1,925,  540 as of Aug. 2003; 7,486 as of 9/11/2007

--------------------------------------------------------------------------------

10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares  (See Instructions) |_|

  --------------------------------------------------------------------------------

11) Percent of Class Represented by Amount in Item 9     3.8%  as of Aug. 2003; .01% as of 9/11/2007

--------------------------------------------------------------------------------

12) Type of Reporting Person (See Instructions) CO

--------------------------------------------------------------------------------

 

**UNITED STATES  SECURITIES AND EXCHANGE COMMISSION  WASHINGTON, DC 20549**

**SCHEDULE 13G**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934  (Amendment No. 1)***

******Genvec, Inc.**  (Name of Issuer)

 Common Stock, $.001 par value  (Title of Class of Securities)

 37246C109  (CUSIP Number)

  December 31, 2003  (Date of Event Which Requires Filing of this Statement)

  Check the appropriate box to designate the rule pursuant to which this Schedule  is filed:

 |_| Rule 13d-1(b)  |X| Rule 13d-1(c)  |_| Rule 13d-1(d)

 *The remainder of this cover page shall be filled out for a reporting  person's initial filing on this form with respect to the subject class of  securities, and for any subsequent amendment containing information which would  alter disclosures provided in a prior cover page.

 The information required on the remainder of this cover page shall not be  deemed to be "filed" for the purpose of Section 18 of the Securities  Exchange  Act of 1934 ("Act") or otherwise subject to the liabilities of that  section of  the Act but shall be subject to all other provisions of the Act (however, see  the Notes).

CUSIP No.  37246C109  --------------------------------------------------------------------------------

1) Names of Reporting Persons. Pfizer Inc.  IRS Identification Nos. of Above Persons (entities only) 13-5315170

--------------------------------------------------------------------------------

2) Check the Appropriate Box if a Member of a Group (See Instructions)  (a) |_|  (b) |_|

--------------------------------------------------------------------------------

3) SEC Use Only

--------------------------------------------------------------------------------

4) Citizenship or Place of Organization  Delaware

--------------------------------------------------------------------------------

| NUMBER OF          SHARES           BENEFICIALLY 

OWNED BY EACH REPORTING

 PERSON WITH: | 5. Sole Voting Power   -0- |
|-------------------------------------------------------------------------------------------|--------------------------------------|
| 6. Shared Voting Power  1,925, 540 as of      Aug. 2003; 7,486 as of 9/11/2007       |
| 7. Sole Dispositive Power  -0-                                                       |
| 8. Shared Dispositive Power   1,925, 540      as of Aug. 2003; 7,486 as of 9/11/2007 |

--------------------------------------------------------------------------------

9) Aggregate Amount Beneficially Owned by Each Reporting Person 1,925, 540  as of Aug. 2003; 7,486 as of 9/11/2007

--------------------------------------------------------------------------------

10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares  (See Instructions) |_|

  --------------------------------------------------------------------------------

11) Percent of Class Represented by Amount in Item 9        3.8%  as of Aug. 2003; .01% as of 9/11/2007

--------------------------------------------------------------------------------

12) Type of Reporting Person (See Instructions) CO

--------------------------------------------------------------------------------

ITEM 1.

(A) NAME OF ISSUER: Genvec, Inc.

(B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICE: 65 W Watkins Mill Rd.,  Gaithersburg, MD 20878

ITEM 2.

(A) NAME OF PERSONS FILING: This statement is being filed by Pfizer Inc., a  Delaware corporation (Pfizer), and Warner-Lambert Company LLC, a Delaware limited  liability company (WL). WL is a wholly-owned subsidiary of Pfizer. The securities  reported herein are directly owned by WL.

(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR IF NONE, RESIDENCE:  235 E. 42nd Street, New York, NY 10017

(C) CITIZENSHIP: DELAWARE

(D) TITLE OF CLASS OF SECURITIES: COMMON STOCK

(E) CUSIP NUMBER: 37246C109

ITEM 3. STATEMENT FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B) OR (C)

Not applicable. 

ITEM 4. OWNERSHIP.

 (a) Amount beneficially owned: 1,925, 540 as of Aug. 2003; 7,486 as of 9/11/2007

 (b) Percent of class:  3.8% as of Aug. 2003; .01% as of 9/11/2007

 (c) Number of shares as to which the person has: 

 (i) Sole power to vote or to direct the vote: -0-

 (ii) Shared power to vote or to direct the vote: 1,925, 540 as of Aug. 2003;  7,486 as of 9/11/2007

 (iii) Sole power to dispose or to direct the disposition of: -0-

 (iv) Shared power to dispose or to direct the disposition of:   1,925,  540 as of Aug. 2003; 7,486 as of 9/11/2007

  ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

If this statement is being filed to report the fact that as of the date hereof  the reporting person has ceased to be the beneficial owner of more than five  percent of the class of securities, check the following |X|.

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

Not applicable.

ITEM 7.  IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED  THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

Not applicable.

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

Not applicable.

ITEM 9. NOTICE OF DISSOLUTION OF GROUP

Not applicable.

ITEM 10. CERTIFICATION.

By signing below I certify that, to the best of my knowledge and belief, the  securities referred to above were not acquired and are not held for the purpose  of or with the effect of changing or influencing the control of the issuer of  the securities and were not acquired and are not held in connection with or  as a  participant in any transaction having that purpose or effect.

**Signature**

  After reasonable inquiry and to the best of my knowledge and belief, I certify  that the information set forth in this statement is true, complete and correct.

Dated: September 11, 2007

 Warner-Lambert Company LLC

 By: /s/ Susan Grant  Name: Susan Grant  Title: Assistant Secretary

PFIZER INC. 

 By: /s/ Lawrence A. Fox  Name: Lawrence A. Fox  Title: Vice President, Assistant General Counsel and  Assistant Secretary